Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind confirmatory phase 3 study of blonanserin in schizophrenia
jRCT2080220098Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of blonanserin in schizophrenia, sponsored by Sumitomo Pharma.
02
Drugs
blonanserin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080220098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220098.